复发性-话题@MedSci

#复发性#

452篇内容 | 2435人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1909992, encodeId=c6f31909992c3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Avelumab与Talazoparib联合治疗有望用于复发性 pMMR 子宫内膜癌, objectType=article, longId=736915, objectId=4bffe369156f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bffe369156f, replyNumber=0, likeNumber=104, createdTime=2022-11-13, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bffe369156f, moduleTitle=Avelumab与Talazoparib联合治疗有望用于复发性 pMMR 子宫内膜癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bffe369156f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909987, encodeId=9cdb190998e9b, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, objectType=article, longId=729208, objectId=e8d9e29208b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d9e29208b5, replyNumber=0, likeNumber=106, createdTime=2023-01-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d9e29208b5, moduleTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8d9e29208b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909989, encodeId=8c44190998997, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤, objectType=article, longId=735741, objectId=dd07e3574140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd07e3574140, replyNumber=0, likeNumber=108, createdTime=2022-11-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd07e3574140, moduleTitle=NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd07e3574140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909993, encodeId=bdbb19099935f, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）, objectType=article, longId=737263, objectId=9229e37263e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9229e37263e8, replyNumber=0, likeNumber=182, createdTime=2022-11-06, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9229e37263e8, moduleTitle=Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9229e37263e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909990, encodeId=ba341909990d3, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin Cancer Res：纳武单抗联合多西他赛治疗晚期或复发性NSCLC, objectType=article, longId=736603, objectId=33d9e36603ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33d9e36603ca, replyNumber=0, likeNumber=222, createdTime=2023-05-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33d9e36603ca, moduleTitle=Clin Cancer Res：纳武单抗联合多西他赛治疗晚期或复发性NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33d9e36603ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909975, encodeId=e07919099e578, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法, objectType=article, longId=728048, objectId=1cb1e28048ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cb1e28048ed, replyNumber=0, likeNumber=124, createdTime=2022-07-01, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cb1e28048ed, moduleTitle=EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cb1e28048ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909974, encodeId=600819099e415, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处, objectType=article, longId=727308, objectId=ab34e27308f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab34e27308f9, replyNumber=0, likeNumber=166, createdTime=2022-06-22, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab34e27308f9, moduleTitle=JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab34e27308f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909985, encodeId=0a1d19099858c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=J Evid Based Dent Pract：纳米颗粒凝胶可有效提高姜黄素治疗复发性口角炎的疗效, objectType=article, longId=732185, objectId=3b24e32185f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b24e32185f7, replyNumber=0, likeNumber=125, createdTime=2023-06-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b24e32185f7, moduleTitle=J Evid Based Dent Pract：纳米颗粒凝胶可有效提高姜黄素治疗复发性口角炎的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b24e32185f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909981, encodeId=523f19099816d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=AJG：内镜下乳头球囊扩张可减少复发性胆总管结石患者的疾病再复发, objectType=article, longId=730073, objectId=896fe3007359, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=896fe3007359, replyNumber=0, likeNumber=108, createdTime=2022-12-28, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=896fe3007359, moduleTitle=AJG：内镜下乳头球囊扩张可减少复发性胆总管结石患者的疾病再复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=896fe3007359)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909977, encodeId=67c719099e73d, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, objectType=article, longId=728521, objectId=9843e28521fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9843e28521fc, replyNumber=0, likeNumber=113, createdTime=2022-12-06, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9843e28521fc, moduleTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9843e28521fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909988, encodeId=4e2b1909988f4, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=NEJM Evid：奥替康唑治疗复发性外阴阴道念珠菌病的疗效和安全性（CL-011和CL-012试验）, objectType=article, longId=734183, objectId=9cfbe3418370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9cfbe3418370, replyNumber=0, likeNumber=128, createdTime=2023-06-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9cfbe3418370, moduleTitle=NEJM Evid：奥替康唑治疗复发性外阴阴道念珠菌病的疗效和安全性（CL-011和CL-012试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9cfbe3418370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909982, encodeId=5ac41909982ed, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Blood：复发性经典霍奇金淋巴瘤反应适应性的挽救治疗, objectType=article, longId=730571, objectId=8d37e30571fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d37e30571fd, replyNumber=0, likeNumber=116, createdTime=2022-08-31, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d37e30571fd, moduleTitle=Blood：复发性经典霍奇金淋巴瘤反应适应性的挽救治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d37e30571fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909980, encodeId=d6961909980cf, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, objectType=article, longId=730182, objectId=b81ce30182de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81ce30182de, replyNumber=0, likeNumber=184, createdTime=2022-09-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81ce30182de, moduleTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81ce30182de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909994, encodeId=74251909994f8, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=ESC 2022：新型抗凝药Asundexian可降低复发性缺血性卒中和TIA风险, objectType=article, longId=737357, objectId=c23ee3735770, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c23ee3735770, replyNumber=0, likeNumber=129, createdTime=2023-04-25, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c23ee3735770, moduleTitle=ESC 2022：新型抗凝药Asundexian可降低复发性缺血性卒中和TIA风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c23ee3735770)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909978, encodeId=155819099e87c, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Heart：复发性心内膜炎的临床特征和结局, objectType=article, longId=728555, objectId=06a6e285555d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06a6e285555d, replyNumber=0, likeNumber=102, createdTime=2022-10-26, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06a6e285555d, moduleTitle=Heart：复发性心内膜炎的临床特征和结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=06a6e285555d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909950, encodeId=a6a9190995005, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=PLOS MED：结果为阴性——阿司匹林预防复发性自发性早产的有效性评估, objectType=article, longId=295182, objectId=4f942951823c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f942951823c, replyNumber=0, likeNumber=145, createdTime=2022-04-12, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f942951823c, moduleTitle=PLOS MED：结果为阴性——阿司匹林预防复发性自发性早产的有效性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f942951823c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909953, encodeId=3cc51909953ba, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效, objectType=article, longId=295320, objectId=cf6e295320e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf6e295320e6, replyNumber=0, likeNumber=107, createdTime=2022-05-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf6e295320e6, moduleTitle=Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf6e295320e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909995, encodeId=484e1909995af, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JACC：扩张型心肌病导致的复发性室速患者的临床预后, objectType=article, longId=738752, objectId=3786e38752b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3786e38752b3, replyNumber=0, likeNumber=125, createdTime=2022-10-24, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3786e38752b3, moduleTitle=JACC：扩张型心肌病导致的复发性室速患者的临床预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3786e38752b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909964, encodeId=1fc519099644a, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率, objectType=article, longId=301347, objectId=117230134e0e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=117230134e0e, replyNumber=0, likeNumber=124, createdTime=2022-08-29, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=117230134e0e, moduleTitle=Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=117230134e0e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1909961, encodeId=52021909961ad, content=<a href='/topic/show?id=8f1f42518d8' target=_blank style='color:#2F92EE;'>#复发性#</a>, objectTitle=JAMA子刊：2万多人的研究发现，LDL-C小于1.8 mmol/L可能会降低复发性中风, objectType=article, longId=300771, objectId=5016300e714f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5016300e714f, replyNumber=0, likeNumber=109, createdTime=2022-11-02, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5016300e714f, moduleTitle=JAMA子刊：2万多人的研究发现，LDL-C小于1.8 mmol/L可能会降低复发性中风, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5016300e714f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

复发性

2020-05-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Avelumab与Talazoparib联合治疗有望用于复发性 pMMR 子宫内膜癌

2022-11-13

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌

2023-01-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM：Teclistamab治疗复发性/难治性多发性骨髓瘤

2022-11-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Circulation：新型抗凝剂可预防复发性缺血性卒中（PACIFIC-Stroke研究）

2022-11-06

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin Cancer Res：纳武单抗联合多西他赛治疗晚期或复发性NSCLC

2023-05-16

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

EClinicalMedicine：一项3期随机、双盲研究表明：MIL60或可作为晚期或复发性非鳞状非小细胞肺癌的替代疗法

2022-07-01

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JNNP:生酮饮食治疗复发性多发性硬化症的II期研究,安全性、耐受性和潜在临床益处

2022-06-22

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

J Evid Based Dent Pract：纳米颗粒凝胶可有效提高姜黄素治疗复发性口角炎的疗效

2023-06-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

AJG：内镜下乳头球囊扩张可减少复发性胆总管结石患者的疾病再复发

2022-12-28

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究

2022-12-06

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

NEJM Evid：奥替康唑治疗复发性外阴阴道念珠菌病的疗效和安全性（CL-011和CL-012试验）

2023-06-03

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Blood：复发性经典霍奇金淋巴瘤反应适应性的挽救治疗

2022-08-31

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤

2022-09-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

ESC 2022：新型抗凝药Asundexian可降低复发性缺血性卒中和TIA风险

2023-04-25

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Heart：复发性心内膜炎的临床特征和结局

2022-10-26

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

PLOS MED：结果为阴性——阿司匹林预防复发性自发性早产的有效性评估

2022-04-12

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效

2022-05-02

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JACC：扩张型心肌病导致的复发性室速患者的临床预后

2022-10-24

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

Lancet子刊：常规使用左旋甲状腺素不能提高甲功正常的TPO-Ab阳性的复发性流产女性的活产率

2022-08-29

hb2008ye (审核中...)

前往app查看评论内容

#复发性#

JAMA子刊：2万多人的研究发现，LDL-C小于1.8 mmol/L可能会降低复发性中风

2022-11-02

科室
- - 订阅+
  - 更多科室
工具
服务